ABSTRACT
OBJECTIVE: To determine the risk factors for a low quality of life in Thai epileptic patients. MATERIAL AND METHOD: A cross-sectional study was conducted at Songklanagarind Hospital, Thailand. Epileptic patients aged 15-50 years old, who had been treated with a stable dose of antiepileptic drug(s) for more than three months, were enrolled Those who had other chronic medical illnesses and pregnant women were excluded. All subjects completed a self-report questionnaire that included questions about the quality of life in epilepsy-31 (QOLIE-31), hospital anxiety, depression score (HADS), age, sex, occupation, marital status, education level, medical insurance, seizure frequency, trauma due to seizure activity, duration of epilepsy, and medication analysis. RESULTS: In the univariate analysis, significant (p < 0.05) factors affecting the quality of life included seizure frequency, history of trauma due to seizures, depression, and anxiety. In the multivariate regression analysis, seizure frequency, anxiety, and depression were significant. Anxiety and depression were significant statistical factors in explaining a lower quality of life. Throughout the results, seizure frequency, depression, and anxiety had an inverse relation to scores. Age, sex, education, medical insurance, occupation, marital status, and medication were not significant for quality of life. In the subscale analysis of quality of life, seizure frequency was associated with seizure worry; occupation with energy/fatigue; anxiety with all subscale QOLIE; depression with emotional well-being, overall, energy/fatigue and cognitive and social functions; marital status with energy/fatigue; and medical insurance with medical effects. CONCLUSION: These findings indicated that mood disorder and seizure frequency could be a powerful predictor for the quality of life.
Subject(s)
Anxiety/diagnosis , Depression/diagnosis , Epilepsy/psychology , Quality of Life , Adolescent , Adult , Anxiety/epidemiology , Anxiety/etiology , Cross-Sectional Studies , Depression/epidemiology , Depression/etiology , Female , Humans , Male , Middle Aged , Multivariate Analysis , Psychometrics , Risk Factors , Statistics as Topic , Surveys and Questionnaires , Thailand/epidemiology , Young AdultABSTRACT
OBJECTIVE: To investigate the reliability and validity of the Thai version of disease-specific health-related quality of life instrument for patients with hemifacial spasm (HFS) as well as their response to botulinum toxin treatment. MATERIAL AND METHOD: A Thai version of HFS-30 has been developed with the permission of the author. Thirty patients with HFS were asked to complete this Thai HFS-30, the 6-point disability scale before treatment and between four and six weeks after botulinum toxin injections. Peak improvement (0-100%) was subjectively assessed by each patient between four and six weeks after injection. They were also asked to answer the existing Thai SF-36 questionnaire before treatment to test its correlation with Thai HFS-30. Another group of ten patients completed the questionnaire and then a second identical copy after a 2-week interval. The reliability, validity, and responsiveness were subsequently analyzed. RESULTS: The Thai HFS-30 showed a Cronbach's alpha coefficient of 0.78 and no significant difference of a test-retest reliability. The total content validity was 0.88 (range 0.5-1.0). There were good correlations between both the Physical and Mental Health parts of the Thai HFS-30 and Thai SF-36 (p < 0.05 and p < 0.01, respectively). The Thai HFS-30 also demonstrated a response to treatment similar to the 6-point disability scale and the peak improvement. CONCLUSION: The Thai version of HFS-30 is a valid, reliable, and sensitive to change instrument for disease specific health-related quality of life assessment.
